AIkido Pharma (AIKI) Competitors $6.49 +0.16 (+2.53%) As of 09/19/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. LUNA, DKDCA, PRE, SKYE, ZURA, ANIK, ONCY, PROF, CGEN, and TARAShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), Prenetics Global (PRE), Skye Bioscience (SKYE), Zura Bio (ZURA), Anika Therapeutics (ANIK), Oncolytics Biotech (ONCY), Profound Medical (PROF), Compugen (CGEN), and Protara Therapeutics (TARA). AIkido Pharma vs. Its Competitors Luna Innovations Data Knights Acquisition Prenetics Global Skye Bioscience Zura Bio Anika Therapeutics Oncolytics Biotech Profound Medical Compugen Protara Therapeutics Luna Innovations (NASDAQ:LUNA) and AIkido Pharma (NASDAQ:AIKI) are both small-cap commercial physical research industry companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Does the media favor LUNA or AIKI? In the previous week, Luna Innovations' average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score. Company Overall Sentiment Luna Innovations Neutral AIkido Pharma Neutral Is LUNA or AIKI more profitable? Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Luna InnovationsN/A N/A N/A AIkido Pharma N/A -18.21%-16.94% Which has preferable earnings and valuation, LUNA or AIKI? Luna Innovations has higher revenue and earnings than AIkido Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLuna Innovations$116.61M0.26$9.28MN/AN/AAIkido PharmaN/AN/A-$7.17M-$3.88-1.67 Which has more risk and volatility, LUNA or AIKI? Luna Innovations has a beta of 2, indicating that its stock price is 100% more volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Do institutionals and insiders hold more shares of LUNA or AIKI? 87.5% of Luna Innovations shares are owned by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are owned by institutional investors. 7.6% of Luna Innovations shares are owned by insiders. Comparatively, 8.6% of AIkido Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryLuna Innovations beats AIkido Pharma on 6 of the 7 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIKI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.60M$21.23M$5.79B$10.49BDividend YieldN/AN/A5.61%4.57%P/E Ratio-1.67N/A348.8926.87Price / SalesN/A0.26522.55164.30Price / CashN/A57.2326.0131.15Price / Book0.340.3415.536.50Net Income-$7.17M-$525K$3.29B$271.42M7 Day Performance-1.07%5.13%200.87%3.69%1 Month Performance16.73%17.73%184.38%8.07%1 Year Performance248.92%78.94%325.51%29.65% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$6.49+2.5%N/A+248.9%$35.60MN/A-1.674High Trading VolumeLUNALuna InnovationsN/A$0.95+10.5%N/A-60.2%$32.26M$116.61M0.00390Gap DownDKDCAData Knights AcquisitionN/A$0.87+3.2%N/A+47.2%$4.50MN/A-4.582High Trading VolumePREPrenetics Global1.0194 of 5 stars$9.49-3.0%$9.00-5.2%+175.2%$126.99M$30.62M-2.381Positive NewsAnalyst RevisionSKYESkye Bioscience1.8531 of 5 stars$3.86-5.2%$15.50+301.6%+27.4%$126.12MN/A-3.6411ZURAZura Bio3.5842 of 5 stars$1.96+2.1%$14.00+614.3%-55.2%$124.83MN/A-2.803ANIKAnika Therapeutics4.4223 of 5 stars$8.65flat$18.00+108.1%-65.1%$124.72M$119.91M-2.08300Positive NewsONCYOncolytics Biotech2.2841 of 5 stars$1.27+2.4%$5.00+293.7%+47.2%$124.45MN/A-4.7030Gap UpPROFProfound Medical1.4657 of 5 stars$4.04-1.2%$11.00+172.3%-44.4%$123.20M$10.68M-2.77150CGENCompugen1.036 of 5 stars$1.38flat$4.00+189.9%-27.3%$123.15M$27.86M-6.2770Positive NewsTARAProtara Therapeutics1.4261 of 5 stars$3.07-2.8%$19.60+538.4%+61.1%$121.92MN/A-1.9030News CoverageGap Up Related Companies and Tools Related Companies Luna Innovations Alternatives Data Knights Acquisition Alternatives Prenetics Global Alternatives Skye Bioscience Alternatives Zura Bio Alternatives Anika Therapeutics Alternatives Oncolytics Biotech Alternatives Profound Medical Alternatives Compugen Alternatives Protara Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThe next AI Hype Spike is days away — don’t miss itOn this date, AI could trigger the kind of predictable surge that's already paid out 61%… 158%… and even 382% ...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
